LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on April 21, 2026

Apr. 21, 2026

Tropigas Modernizes Mission-Critical Energy Operations with Creatio

Indeterminate EIN Presswire

Apr. 21, 2026

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

CortexForge Marks Year One with Integration as the First Proof

Indeterminate EIN Presswire

Apr. 21, 2026

Emerita Comments on Press Release Issued by Denarius Metals

Indeterminate GlobeNewswire

Apr. 21, 2026

TIGHITCO Expands Engine Program Support Across Defense Applications

Indeterminate EIN Presswire

Apr. 21, 2026

Aeroméxico Reports Unaudited First Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 21, 2026

Global Teff Grain for Gluten-Free Baked Goods Market Grows as Mexico Emerges, Led by Bob’s Red Mill & Teff Company

Indeterminate EIN Presswire

Apr. 21, 2026

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

GCC Reports First Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 21, 2026

Oculis Publishes Invitation to the Annual General Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

CEO de Janus Assurance Re agasaja con 'pizza party' a las niñas del Hogar Escuela Doña Chucha

Indeterminate EIN Presswire

Apr. 21, 2026

HYBE LATIN AMERICA AND SIENTO RECORDS PRESENT 'LOW CLIKA: THE SERIES' FOR THE RELEASE OF THEIR DEBUT ALBUM

Indeterminate EIN Presswire

Apr. 21, 2026

EBANX expands recurring alternative payments offering, unlocks a 1 billion user potential across 12 emerging markets

Indeterminate GlobeNewswire

Apr. 21, 2026

Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire